The treatment of bolus TRAIL in HCT-116 cells resulted in early cancer death due to the highly available TRAIL amount, whereas cancer reproliferated after 7 days since the bioactivity of bolus TRAIL decreased over time. The gene discussed is TNFSF10; the disease is cancer.